AGL 40.39 Increased By ▲ 0.38 (0.95%)
AIRLINK 126.80 Decreased By ▼ -1.19 (-0.93%)
BOP 6.60 No Change ▼ 0.00 (0%)
CNERGY 4.51 Decreased By ▼ -0.09 (-1.96%)
DCL 8.52 Increased By ▲ 0.04 (0.47%)
DFML 41.75 Increased By ▲ 0.27 (0.65%)
DGKC 86.90 Increased By ▲ 0.32 (0.37%)
FCCL 32.30 Increased By ▲ 0.16 (0.5%)
FFBL 65.00 Decreased By ▼ -0.42 (-0.64%)
FFL 10.15 Decreased By ▼ -0.10 (-0.98%)
HUBC 109.58 Decreased By ▼ -0.91 (-0.82%)
HUMNL 14.60 Decreased By ▼ -0.15 (-1.02%)
KEL 5.12 Decreased By ▼ -0.01 (-0.19%)
KOSM 7.55 Increased By ▲ 0.43 (6.04%)
MLCF 41.30 Decreased By ▼ -0.35 (-0.84%)
NBP 59.53 Decreased By ▼ -0.56 (-0.93%)
OGDC 194.99 Increased By ▲ 0.30 (0.15%)
PAEL 28.27 Increased By ▲ 0.32 (1.14%)
PIBTL 7.77 Decreased By ▼ -0.23 (-2.88%)
PPL 152.49 Increased By ▲ 1.32 (0.87%)
PRL 26.65 Decreased By ▼ -0.23 (-0.86%)
PTC 16.10 Increased By ▲ 0.10 (0.63%)
SEARL 79.06 Increased By ▲ 0.86 (1.1%)
TELE 7.47 Increased By ▲ 0.08 (1.08%)
TOMCL 35.49 Decreased By ▼ -0.18 (-0.5%)
TPLP 8.30 Increased By ▲ 0.39 (4.93%)
TREET 16.05 Increased By ▲ 0.16 (1.01%)
TRG 53.00 Increased By ▲ 0.24 (0.45%)
UNITY 26.75 Increased By ▲ 0.20 (0.75%)
WTL 1.25 Decreased By ▼ -0.02 (-1.57%)
BR100 9,892 Decreased By -28 (-0.28%)
BR30 30,712 Decreased By -39.5 (-0.13%)
KSE100 93,299 Increased By 74.2 (0.08%)
KSE30 28,916 Increased By 31.3 (0.11%)

GENEVA: The World Health Organization on Friday approved Johnson & Johnson's Covid-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Oxford-AstraZeneca.

"Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic," WHO chief Tedros Adhanom Ghebreyesus said in a statement.

The news comes after the single-dose jab won approval from the European Union on Thursday.

It has also received the green light from regulators in the United States, Canada and South Africa.

The World Health Organization said the J&J jab had been granted an "emergency use listing" which assesses the suitability of new health products during public health emergencies, and is quicker than the regular licensing system.

Comments

Comments are closed.